Skip to main content

Perineoplasty + De-Adhesion for Vulvar Lichen Sclerosus

Perineoplasty and targeted de-adhesion are options for symptomatic vulvar lichen sclerosus (LS) sequelae — persistent introital stenosis, labial / periclitoral adhesions or clitoral phimosis — despite guideline-conform topical treatment. They address scarred anatomy, not the underlying inflammatory disease. Plan topical corticosteroid treatment before and after surgery, with longer-term maintenance tailored to disease activity rather than a fixed indefinite clobetasol dose.[1][11] For broader LS context see Lichen Sclerosus; for the surgical algorithm placement see the Vulvar Reconstruction database.


Indications

Surgery is reserved for established, function-limiting architectural sequelae of LS despite appropriate topical therapy; the 2026 consensus guideline specifically suggests de-adhesion, perineoplasty or anatomic vulvoplasty for persistent stenosis causing mechanical problems with voiding or intercourse. It suggests against routine surgery for girls, apart from selected functional impairments.[1][3][11]

  • Refractory dyspareunia or apareunia from introital stenosis despite adequate clobetasol
  • Clitoral phimosis with pain or sexual dysfunction
  • Labial / periclitoral adhesions restricting introital access or burying the meatus
  • Complete introital obliteration causing urinary retention — rare but reported[5]
  • Patient-stated desire to resume sexual activity is a core selection criterion[1]

Maximally treat LS topically before surgery; surgery does not replace medical therapy.[1][2]


Procedures — simplest to most complex

Selection is driven by anatomic distribution of scar (posterior band vs anterior vestibule vs clitoral hood vs circumferential) and prior surgical history. Components are routinely combined in a single operative session. No randomized trial compares techniques head-to-head; the procedural detail below is consolidated from the available retrospective series.

1. Fenton's procedure (median perineotomy)

Simplest, least invasive option — one of the two most commonly performed procedures in Gurumurthy's 10-year series.[7]

  • Technique: single midline incision through the scarred posterior fourchette / perineum dividing the constricting fibrotic band; closure transversely to widen the introitus (Heineke–Mikulicz principle).
  • Best for: mild-to-moderate posterior introital stenosis with a discrete constricting band.
  • Advantages: quick, minimal excision, feasible under local anesthesia, low morbidity.
  • Limitations: does not address circumferential scarring, anterior vestibular disease, or clitoral phimosis; less widening than full vestibuloplasty.

2. CO₂ laser adhesiolysis

The other commonly performed Gurumurthy technique.[7]

  • Technique: CO₂-laser division of labial / periclitoral adhesions; protect adjacent tissue and use an appropriate laser setting.
  • Best for: isolated labial / periclitoral adhesions (clitoral phimosis) without significant posterior stenosis.
  • Potential advantages: controlled division and hemostasis; comparative benefit over careful sharp release has not been established here.
  • Re-adhesion prophylaxis: after sharp lysis in three adolescents with recurrent adhesions, Surgicel (oxidized regenerated cellulose) was sutured to exposed surfaces; none had recurrence at one year. This case report does not establish a routine prophylactic standard.[10]

3. Posterior vestibuloplasty (perineoplasty) with vaginal mucosal advancement

The workhorse operation for LS-related introital stenosis, with the largest evidence base (Rouzier, Lauber).[1][3][6]

Operative steps:

  1. Transverse or inverted-U incision at the posterior fourchette / perineal body.
  2. En-bloc excision of scarred, fibrotic perineal skin and underlying tissue.
  3. Mobilization of posterior-vaginal-wall mucosa inferiorly to cover the defect without excessive closure tension.
  4. Suture of vaginal mucosa to perineal skin edges, replacing scarred introital tissue with supple vaginal epithelium.
  • Best for: moderate-to-severe posterior introital stenosis.
  • Outcomes: Rouzier reported dyspareunia improvement in 45/50 evaluable women and improved sexual quality in 43/50 (64 operated); Lauber reported less dyspareunia (p = 0.02) and 37/41 satisfied or very satisfied (70 invited; 41 responded). These selected retrospective cohorts are not comparative efficacy estimates.[1][3]
  • Histology: evaluate suspicious new, hyperkeratotic, eroded or ulcerated lesions with biopsy to exclude differentiated VIN or SCC. Lauber submitted all excised specimens; this series protocol is not proof that all otherwise benign excisions must be sent in every setting.[1][11]

4. Clitoral de-hooding (clitoral unroofing)

  • Technique: sharp excision of the scarred, fused prepuce overlying the glans clitoridis; expression of entrapped keratin debris ("smegma pearls") and hair.
  • Best for: clitoral phimosis with pain, sexual dysfunction, or retained keratinaceous material.
  • Outcomes: 4 patients in the Burger series, all without complications.[6]
  • Caution: dorsal nerve of the clitoris runs immediately deep — meticulous dissection is essential to preserve sensation.

5. Anterior vestibuloplasty with free full-thickness vaginal mucosal graft

Novel, investigational variant described by Burger and Obdeijn.[6]

  • Technique: excise scarred anterior vestibular tissue → harvest full-thickness vaginal mucosa from the anterior or posterior vaginal wall as described in the series → inset the graft into the anterior vestibular defect.
  • Best for: anterior vestibular stenosis / scarring not addressable by posterior vestibuloplasty alone; typically circumferential introital involvement.
  • Complications: 1/5 patients in the index series required reoperation for graft contraction and keratinization; the role of postoperative estrogen in maintaining graft viability is undefined.
  • Status: investigational; deserves further study.

6. Local skin-flap advancement

Plastic-surgery approach for extensive sequelae — local Y-V / V-Y / pubolabial advancement or rhomboid / lotus-petal / gluteal-fold pivoting designs after excision of scarred tissue. In Rangatchew's selected 38-person flap series, dyspareunia was reported by 33 before surgery and five at short-term follow-up (seven outcomes unknown); 74% of survey respondents were satisfied or very satisfied, but recurrent LS-related pain was common over a mean 8.4-year clinical follow-up. Full long-term data and the Brauer 2016 qualitative findings live on the dedicated page: see Local Skin Flaps for LS Sequelae.[8]

7. aOAP flap (last-resort reconstruction)

Highly specialized option for selected refractory cases — skinning vulvectomy with bilateral perforator-flap reconstruction. This replaces tissue but does not cure LS or remove the need for disease surveillance. Detailed on the dedicated atlas page: see aOAP Flap (O'Dey).


Choosing the appropriate technique

No randomized data; selection follows anatomic distribution and surgeon expertise.

Clinical scenarioRecommended techniqueRationale
Isolated posterior constricting band, mild stenosisFenton's procedureSimplest, quickest, lowest morbidity
Isolated labial / periclitoral adhesionsTargeted sharp or laser adhesiolysisChoose the method for the anatomy; Surgicel evidence is a three-person report
Moderate-severe posterior introital stenosisPosterior vestibuloplasty + vaginal advancementReported in the larger available retrospective cohorts
Clitoral phimosisClitoral de-hoodingTargeted, low complication rate
Anterior vestibular involvementAnterior vestibuloplasty + mucosal graftNovel; addresses anterior scarring
Multi-site involvementCombined session (perineoplasty + de-hooding + adhesiolysis)One-stage anatomic correction
Extensive scarring / failed prior surgeryLocal skin flaps (Rangatchew)Maximum tissue recruitment
Severe refractory disabling scarringSpecialist assessment for aOAP or other flapSelected salvage reconstruction, not definitive LS cure

Outcomes

StudynProcedureDyspareunia / sexual outcomeSatisfactionFollow-up
Rouzier 2002[3]64 (50 evaluated)Perineoplasty45/50 improved dyspareunia43/50 improved sexual qualityVariable
Gurumurthy 2012[7]25Fenton's / laser adhesiolysis80% improved after initial surgeryTen-year study period, not ten-year follow-up
Burger 2016[6]23Posterior vestibuloplasty ± de-hooding ± graftingComplications-focused reportMedian observation 32 months; 2008–2012 surgery period
Rangatchew 2017[8]38Local skin flaps33 reported dyspareunia before, five at short-term follow-up (seven unknown); 75% of those with preoperative dyspareunia reported benefit74% satisfied / very satisfiedMean 8.4 yr clinical follow-up; 78% follow-up rate
Lauber 2021[1]70 invited; 41 respondedPerineoplasty ± de-adhesion (18/41)General complaints decreased (p < 0.001); dyspareunia decreased (p = 0.02), but 10/27 respondents to that question still had intercourse pain37/41 satisfied or very satisfied; 39/41 would recommendMedian 2.3 yr

These small, selected, uncontrolled series suggest that many patients benefit, but differing procedures, denominators, follow-up and nonresponse limit any pooled success claim. Rouzier, not Lauber, reported no association between the baseline factors it tested and failure; that does not exclude clinically important predictors.[1][3][7]


Complications

Generally safe but specific issues include:[6]

  • Wound dehiscence / infection of advanced vaginal epithelium
  • LS reactivation with bullae — reported in one Burger patient after postoperative steroid interruption; this single event is a caution, not a quantified risk estimate
  • Localized pain (~13% in one series; causality uncertain)
  • Graft contraction / keratinization when anterior vestibuloplasty with mucosal graft is performed

Long-Term Recurrence — the Defining Caveat

Surgery does not modify LS biology. Among Rangatchew's long-term followed patients, recurrent dyspareunia was attributed to minor LS relapse in 50% (coitus preserved) and more severe relapse in 38% (apareunia); the series had incomplete long-term follow-up and should not be read as a universal recurrence probability.[8] Counsel about recurrence even after technically successful repair. In Lauber's different cohort, 23/41 required intensified topical treatment for LS activity; that is not the same endpoint as repeat stenosis.[1]


Perioperative Principles

  • Preop: maximize topical-steroid disease control; document LS extent; consent for relapse risk.
  • Histology: biopsy any suspicious new or changing lesion; submit excised tissue when needed for diagnosis or to exclude neoplasia. Do not infer an individual cancer risk from a single broad historical percentage.[11]
  • Postop topical steroids: agree on perioperative treatment and individualized maintenance. Lauber used daily clobetasol or mometasone before and for four weeks after surgery, then encouraged twice-weekly maintenance; this is a series protocol, not a universal dose.[1][11]
  • Vaginal dilators: consider after healing when appropriate; Lauber encouraged use from four weeks postoperatively, but its observational data did not establish a benefit from dilation.[1]
  • Long-term follow-up for symptom control, treatment adjustment and surveillance for suspicious lesions; the 2026 guideline suggests review about every 3–6 months initially and yearly when stable, individualized to risk.[11]

Positioning in the LS Surgical Ladder

SeverityPreferred approach
Refractory introital stenosis / focal adhesionsPerineoplasty + de-adhesion (this page)
Extensive sequelae with sexual dysfunction unresponsive to conservative careSkinning vulvectomy + aOAP flap (O'Dey)
Complementary regenerative optionMicrofat / nanofat ± PRP / SVF (see VLS section)
Clitoral burying without broader sequelaeTargeted de-adhesion/de-hooding for LS; Foldès reconstruction is a separate FGM/C procedure, not a routine LS adjunct

See Also

Broader clinical background is available in the ACOG practice bulletin and two clinical reviews; their full texts were not used to establish the study-specific outcomes above.[2][4][9]


References

1. Lauber F, Vaz I, Krebs J, Günthert AR. Outcome of perineoplasty and de-adhesion in patients with vulvar lichen sclerosus and sexual disorders. Eur J Obstet Gynecol Reprod Biol. 2021;258:38–42. doi:10.1016/j.ejogrb.2020.12.030

2. Committee on Practice Bulletins–Gynecology. Diagnosis and management of vulvar skin disorders: ACOG Practice Bulletin No. 224. Obstet Gynecol. 2020;136(1):e1–e14. doi:10.1097/AOG.0000000000003944

3. Rouzier R, Haddad B, Deyrolle C, et al. Perineoplasty for the treatment of introital stenosis related to vulvar lichen sclerosus. Am J Obstet Gynecol. 2002;186(1):49–52. doi:10.1067/mob.2002.119186

4. Pérez-López FR, Vieira-Baptista P. Lichen sclerosus in women: a review. Climacteric. 2017;20(4):339–347. doi:10.1080/13697137.2017.1343295

5. Frigerio M, Barba M, Volontè S, et al. Total introital obliteration as a consequence of lichen sclerosus: a rare cause of urinary retention. Int Urogynecol J. 2023;34(3):779–781. doi:10.1007/s00192-022-05356-6

6. Burger MP, Obdeijn MC. Complications after surgery for the relief of dyspareunia in women with lichen sclerosus: a case series. Acta Obstet Gynecol Scand. 2016;95(4):467–472. doi:10.1111/aogs.12852

7. Gurumurthy M, Morah N, Gioffre G, Cruickshank ME. The surgical management of complications of vulval lichen sclerosus. Eur J Obstet Gynecol Reprod Biol. 2012;162(1):79–82. doi:10.1016/j.ejogrb.2012.01.016

8. Rangatchew F, Knudsen J, Thomsen MV, Drzewiecki KT. Surgical treatment of disabling conditions caused by anogenital lichen sclerosus in women: an account of surgical procedures and results, including patient satisfaction, benefits, and improvements in health-related quality of life. J Plast Reconstr Aesthet Surg. 2017;70(4):501–508. doi:10.1016/j.bjps.2016.12.008

9. Ringel NE, Iglesia C. Common benign chronic vulvar disorders. Am Fam Physician. 2020;102(9):550–557.

10. Breech LL, Laufer MR. Surgicel in the management of labial and clitoral hood adhesions in adolescents with lichen sclerosus. J Pediatr Adolesc Gynecol. 2000;13(1):21–22. doi:10.1016/s1083-3188(99)00029-7

11. Kirtschig G, et al. Evidence- and consensus-based guideline on lichen sclerosus. J Dtsch Dermatol Ges. 2026. doi:10.1111/ddg.70000